Member Info for 1pencil

L’Occitane Chairman Launches Buyout at €6 Billion Valuation

https://www.bloomberg.com/news/articles/2024-04-29/billionaire-launches-l-occitane-buyout-at-6-4-billion-valuation

Share are trading at a five year high even before this latest approach.

AMVACs GreenSolutions as the division mentioned in the press release, video gives a good overview including fermentation facilities and various manufacturing plants, or to put it another way - everything you need to scale Plant healthcare's extensive portfolio.

https://www.amvac.com/greensolutions

Too slow lol, interesting Kelso dedicate a paragraph to this as its featured quite a bit on here too.

L’Occitane’, M & A swirling around all sides, THG in the midst of it..

'THG can implement is to move its listing on the LSE from the standard list to the premium index. THG currently has very few passive indexed holders and most UK active fund managers do not have to consider an investment in THG as it is not in their performance benchmark of the premium index.

We hope that this change of index happens in 2024 either naturally through the FCA changes or that THG is proactive and makes the change of listing itself.'

L’Occitane’s billionaire owner to take firm private in $1.8 billion deal

PUBLISHED MON, APR 29 202411:34 AM EDT

https://www.cnbc.com/2024/04/29/loccitanes-billionaire-owner-to-take-firm-private-in-1point8-billion-deal.html

ELEMIS partnered with THG Ingenuity in 2020 to expand its DTC operations to new markets, launching 16 new sites across Europe and APAC in just 10 months.

https://www.thgingenuity.com/resources/case-studies/delivering-international-dtc-expansion-ingenuity-commerce-x-elemis

Approaching round numbers $20, always a favourite for prop traders as investors breath a sigh of relief crossing said threshold, only for the rug to be unceremoniously pulled from under ..

Https://www.balderton.com/news/darktrace-goes-public-on-the-london-stock-exchange/

https://www.balderton.com/news/balderton-portfolio-company-thg-goes-public-on-the-london-stock-exchange/

Par for the course, see comments on results day..

I can see why PHC put a lot of emphasis and effort into Brazilian market, the graph further down on sugarcane illustrates this well.

https://news.agropages.com/News/NewsDetail---49913.htm

Its very likely UK and Eurozone along with Asia will end up with declining interest rates on the back of receding inflation, US being the odd dude out.

Its a long time since this scenario last played out, but given the chronic undervaluation's of UK stocks this can only act as a tailwind ..

Agreed bots, also enhances the company to any prospective suitors, PHC now has a sizable foot print for leveraging.

Plant healthcare now has approvals in 3 of the six of high end EU producers:

'About three-quarters (76.8 %) of the EU’s cultivated area of potatoes in 2020 was concentrated in just six Member States: these were Poland (a provisional 21.6 %), Germany (16.5 %), France (12.9 %), Romania (10.0 %), the Netherlands (9.9 %) and Belgium (a provisional 5.9 %).'

https://ec.europa.eu/eurostat/statistics-explained/index.php?title=The_EU_potato_sector_-_statistics_on_production,_prices_and_trade

This approval differs from last three as mentions 'permits immediate sales of Harpinαβ in Belgium', presumably this is due to Belgium being in the Northern Hemisphere with growing season about to commence.

Target market appears to be potatoes, plenty of supporting data to validate sales.

More good news, that's both approvals granted in Mexico leaving just OBRONA in California awaiting approval.

COFEPRIS APPROVES THE REGISTRATION OF TEIKKO™ AND SAORI™ IN MEXICO Plant Health Care, Inc., announces the COFEPRIS (Federal Committee for Protection from Sanitary Risks) registration of its PHC25279 and PHC68949 products (our SAORI™ and TEIKKO™).

https://www.linkedin.com/posts/plant-health-care-brasil_agro-agronegaejcio-phc-activity-7186721438744104961-JBZN/

With the exception of UK and Poland, AMVAC have operations in the same locations as Plant healthcare, this would make it easy to scale existing registrations fast rather than starting from scratch.

Economies of scale is key here, scale is everything.

Crafty, thanks for the posts today, plenty to absorb which would have otherwise passed me by.

Its worth having a look at AMVAC BioSolutions portfolio, mostly through acquisitions:

Our biological solutions are brought to market by an array of American Vanguard’s companies, technologies, distribution arms, investments, and partnerships, including:

https://www.american-vanguard.com/about/green-solutions-our-growing-global-biological-profile

This was from the footer of today's announcement just in case anyone (like me) missed it:

http://agrinos.com/

'Agrinos Shanghai is a business of American Vanguard in China.

It operates import, production, and direct distribution in China. Its primary focus is distribution of AMVAC's GreenSolutions product portfolio and using a technical sales model focusing on biological solutions with positive returns to growers.

Agrinos China has experienced double-digit growth over the last few years and has expanded its geographical reach into new territories with China'

AMVAC is one of several companies I follow in an effort to gauge supply/demand, from their March 14th earnings release:

Eric Wintemute, Chairman and CEO of American Vanguard, stated: "We rebounded sharply in Q4 after having weathered the effect of global destocking within the distribution channel, the oversupply of Chinese generic products into multiple regions, and the unavailability of our most profitable products due to supply chain issues.

Increased demand during Q4 provided evidence that destocking activity continues to subside and that, even while showing greater discipline, procurement within the distribution channel is following more normal patterns.'

https://finance.yahoo.com/news/american-vanguard-reports-fourth-quarter-202600549.html

CVC has revived plans to list in Amsterdam in a deal worth up to £13billion in a fresh setback for London.

The private equity giant abandoned an initial public offering (IPO) in 2022 and again in 2023 due to market uncertainty.

But despite ongoing conflict in the Middle East, sources say the buyout firm is confident that the listing will go ahead.

Daily Mail